Latest Breaking News On - Society for neurooncology national cancer institute - Page 1 : comparemela.com
Yumanity Therapeutics Reports Second Quarter 2021 Financial Results and Recent Corporate
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Yumanity Therapeutics : Reports Second Quarter 2021 Financial Results and Recent Corporate Developments (Form 8-K)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Yumanity Therapeutics Announces Study Demonstrating In Vivo Efficacy of YTX-7739 in a .
Yumanity Therapeutics IncApril 6, 2021 GMT
YTX-7739 demonstrates efficacy, including increased median overall survival, both as a single agent and in combination with temozolomide, the standard-of-care for GBM
Shared therapeutic target with Parkinson’s disease expands potential utility of
YTX-7739 to non-neurodegenerative diseases
SNO/NCI Joint Symposium: Targeting CNS Tumor Metabolism
BOSTON, April 06, 2021 (GLOBE NEWSWIRE) Yumanity Therapeutics (NASDAQ: YMTX), a biopharmaceutical company focused on the development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced results of a study that demonstrate